These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994 [TBL] [Abstract][Full Text] [Related]
3. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels. Mansour M; Mansour S; Mortada ND; Abd Elhady SS Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913 [TBL] [Abstract][Full Text] [Related]
4. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related]
5. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue. Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516 [TBL] [Abstract][Full Text] [Related]
6. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392 [TBL] [Abstract][Full Text] [Related]
7. Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review. Irimia T; Dinu-Pîrvu CE; Ghica MV; Lupuleasa D; Muntean DL; Udeanu DI; Popa L Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30304825 [TBL] [Abstract][Full Text] [Related]
8. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution. Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932 [TBL] [Abstract][Full Text] [Related]
9. Formulation of Ocular In Situ Gels with Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation In Vitro. Perminaite K; Marksa M; Stančiauskaitė M; Juknius T; Grigonis A; Ramanauskiene K Molecules; 2021 Jun; 26(12):. PubMed ID: 34200887 [TBL] [Abstract][Full Text] [Related]
10. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. Mura P; Mennini N; Nativi C; Richichi B Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194 [TBL] [Abstract][Full Text] [Related]
11. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180 [TBL] [Abstract][Full Text] [Related]
12. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits. Abdelkader H; Mansour HF Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945 [TBL] [Abstract][Full Text] [Related]
13. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel. Khan S; Warade S; Singhavi DJ J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593 [TBL] [Abstract][Full Text] [Related]
15. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Gratieri T; Gelfuso GM; Rocha EM; Sarmento VH; de Freitas O; Lopez RF Eur J Pharm Biopharm; 2010 Jun; 75(2):186-93. PubMed ID: 20188828 [TBL] [Abstract][Full Text] [Related]
16. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953 [TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive in situ forming gel for oral mucositis pain control. Li T; Bao Q; Shen J; Lalla RV; Burgess DJ Int J Pharm; 2020 Apr; 580():119238. PubMed ID: 32194210 [TBL] [Abstract][Full Text] [Related]
18. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time. Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970 [TBL] [Abstract][Full Text] [Related]
19. Thermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcers. Sandri G; Bonferoni MC; Rossi S; Ferrari F; Mori M; Del Fante C; Perotti C; Caramella C Int J Pharm; 2012 Apr; 426(1-2):1-6. PubMed ID: 22248667 [TBL] [Abstract][Full Text] [Related]
20. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system. Cao F; Zhang X; Ping Q Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]